HYE WON CHANG: Open Payments
NPI 1780425967 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 30 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $52 · 2025 $749
Food & beverage: $679Education: $70
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $153 |
| AstraZeneca Pharmaceuticals LP | 4 | $125 |
| Stryker Corporation | 1 | $76 |
| Daiichi Sankyo Inc. | 2 | $54 |
| Merck Sharp & Dohme LLC | 2 | $40 |
| EMD Serono, Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $29 |
| Incyte Corporation | 1 | $29 |
| TerSera Therapeutics LLC | 1 | $28 |
| Astellas Pharma US Inc | 1 | $28 |
Products named: LYNPARZA, STRYKER NAV3I, RYBREVANT, DATROWAY, KEYTRUDA, DARZALEX, WAYRILZ, MONJUVI.
Industry payments across AZ — which companies pay providers there.
